Histological grading in colorectal cancer: New insights and perspectives

Histology and Histopathology

Volumn 30, Issue 9, 2015, Pages 1059-1067

  Barresi, Valeria ^a   Bonetti, Luca Reggiani ^b   Leni, Antonio ^a   Caruso, Rosario Alberto ^a   Tuccari, Giovanni ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Colorectal; Grading; Micropapillary; Mucinous; PDC

Indexed keywords

CANCER GRADING; COLORECTAL TUMOR; HUMAN; PATHOLOGY; PROCEDURES;

COLORECTAL NEOPLASMS; HUMANS; NEOPLASM GRADING;

EID: 84938581416     PISSN: 02133911     EISSN: 16995848     Source Type: Journal    
DOI: 10.14670/HH-11-633     Document Type: Review

References (43)

1. Barresi V. and Tuccari G. (2013). Colorectal carcinoma grading quantified by counting poorly differentiated clusters: is it feasible on endoscopic biopsies? Am. J. Surg. Pathol. 37, 943-945.
2. Barresi V. and Reggiani Bonetti L. (2015). Correlation between microsatellite instability status and grading assessed by the counting of poorly differentiated clusters in colorectal cancer. Hum. Pathol. (in press). doi:10.1016/j.humpath.2015.02.018.
3. Barresi V., Reggiani Bonetti L., Branca G., Di Gregorio C., Ponz de Leon M. and Tuccari G. (2012). Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. Virchows Arch. 461, 621-628.
4. Barresi V., Bonetti L.R., Ieni A., Branca G., Baron L. and Tuccari G. (2014a) Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients. Hum. Pathol. 45, 268-275.
5. Barresi V., Branca G., Ieni A., Reggiani Bonetti L., Baron L., Mondello S. and Tuccari G. (2014b). Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer. Virchows Arch. 464, 655-662.
6. Barresi V., Branca G., Vitarelli E. and Tuccari G. (2014c). Micropapillary pattern and poorly differentiated clusters represent the same biological phenomenon in colorectal cancer: a proposal for a change in terminology. Am. J. Clin. Pathol. 142, 375-383.
7. Barresi V, Reggiani Bonetti L and Bettelli S. (2015). KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: observational analysis of 175 cases. Pathology. (in press).
8. Beaton C., Twine C.P., Williams G.L. and Radcliffe A.G. (2013). Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Dis. 15, 788-797.
9. Burton S., Eddy B., Li W.Y., Reddy K., Aslam M., Owen E. and Weston J. (2003). Reliability of pre-operative biopsies in the histological grading of colorectal adenocarcinomas. Ann. R. Coll. Surg. Engl. 85, 23-25.
10. Chandler I. and Houlston R.S. (2008). Interobserver agreement in grading of colorectal cancers-findings from a nationwide web-based survey of histopathologists. Histopathology 52, 494-499.
11. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L. and Trotti A.E. (2010). AJCC Cancer Staging Manual. 7th ed. Springer. New York. pp 143-164.
12. Fiehn A.M., Grauslund M., Glenthøj A., Melchior L.C., Vainer B. and Willemoe G.L. (2015). Medullary carcinoma of the colon: can the undifferentiated be differentiated? Virchows Arch. 466, 13-20.
13. Guaita S., Puig I., Franci C., Garrido M., Dominguez D., Batlle E., Sancho E., Dedhar S., De Herreros A.G. and Baulida J. (2002). Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 277, 39209-39216.
14. Haigis K.M., Kendall K.R., Wang Y., Cheung A., Haigis M.C., Glickman J.N., Niwa-Kawakita M., Sweet-Cordero A., Sebolt-Leopold J., Shannon K.M., Settleman J., Giovannini M. and Jacks T. (2008). Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet. 40, 600-608.
15. Hamilton S.R., Volgelstein B., Kudo S., Riboli E., Nakamura S, Hainaut P, Rubio C.A., Sobin L.H, Fogt F, Winawer S.J., Goldgar D.E. and Jass J.R. (2000). Carcinoma of the colon and rectum. In: Pathology and genetics of tumours of the digestive system. Hamilton S.R. and Aaltonen L.A. (eds).. IARC Press. Lyon. pp 104-119.
16. Hamilton S.R., Bosman F.T., Boffetta P., Ilyas M., Morreau H., Nakamura S.I., Quirke P., Riboli E. and Sobin L.H. (2010). Carcinoma of the colon and rectum. In: WHO classification of tumors of the digestive system. Bosman T., Carneiro F., Hruban R.H. and Theise N.D. (eds). IARC Press. Lyon. pp 134-146.
17. Kalluri R. and Weinberg R.A. (2009). The basics of epithelialmesenchymal transition. J. Clin. Invest. 119, 1420-1428.
18. Kim M.J., Hong S.M., Jang S.J., Yu E., Kim J.S., Kim K.R., Gong G. and Ro J.Y. (2006). Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma. Hum. Pathol. 37, 809-815.
19. Kim J.W., Shin M.K. and Kim B.C. (2015). Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinoma. J. Korean Med. Sci. 30,16-23.
20. Langner C., Harbaum L., Pollheimer M.J., Kornprat P., Lindtner R.A., Schlemmer A., Vieth M. and Rehak P. (2012). Mucinous differentiation in colorectal cancer--indicator of poor prognosis? Histopathology 60,1060-1072.
21. Lanza G., Gafa R., Matteuzzi M. and Santini A. (1999). Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J. Clin. Oncol. 17, 2429-2438.
22. Leslie Sobin M.G. and Wittekind C. (2009). TNM classification of malignant tumors. Wiley Blackwell. Chichester. pp 100-105.
23. Lino-Silva L.S., Salcedo-Hernández R.A. and Caro-Sánchez C.H. (2012). Colonic micropapillary carcinoma, a recently recognized subtype associated with histological adverse factors: clinicopathological analysis of 15 cases. Colorectal Dis.14, e567-e572.
24. Mekenkamp L.J., Heesterbeek K.J., Koopman M., Tol J., Teerenstra S., Venderbosch S., Punt C.J. and Nagtegaal I.D. (2012). Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur. J. Cancer 48, 501-509.
25. Nakadoi K., Tanaka S., Kanao H., Terasaki M., Takata S., Oka S., Yoshida S., Arihiro K. and Chayama K. (2012) Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J. Gastroenterol. Hepatol. 27, 1057-1062.
26. Prall F. and Ostwald C (2007). High-degree tumor budding and podiaformation in sporadic colorectal carcinomas with K-ras gene mutations. Hum. Pathol. 38, 1696-1702.
27. Rachagani S., Senapati S., Chakraborty S., Ponnusamy M.P., Kumar S., Smith L.M., Jain M. and Batra S.K. (2011). Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. Br. J. Cancer 104, 1038-1048.
28. Rosty C., Williamson E.J., Clendenning M., Walters R.J., Win A.K., Jenkins M.A., Hopper J.L., Winship I.M., Southey M.C., Giles G.G., English D.R. and Buchanan D.D. (2014). Should the grading of colorectal adenocarcinoma include microsatellite instability status? Hum. Pathol. 45, 2077-2084.
29. Sakamoto K., Watanabe M., De La Cruz C., Honda H., Ise H., Mitsui K., Namiki K., Mikami Y., Moriya T. and Sasano H. (2005). Primary invasive micropapillary carcinoma of the colon. Histopathology 47, 479-484.
30. Satow R., Hirano T., Batori R., Nakamura T., Murayama Y. and Fukami K. (2014). Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 111, 13505-13510.
31. Shao D.D., Xue W., Krall E.B., Bhutkar A., Piccioni F., Wang X., Schinzel A.C., Sood S., Rosenbluh J., Kim J.W., Zwang Y., Roberts T.M., Root D.E., Jacks T. and Hahn W.C. (2014). KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 158, 171-184.
32. Sugao Y., Yao T., Kubo C. and Tsuneyoshi M. (1997). Improved prognosis of solid-type poorly differentiated colorectal adenocarcinoma: a clinicopathological and immunohistochemical study. Histopathology 31, 123-133.
33. Tytherleigh M.G., Warren B.F. and Mortensen N.J. (2008). Management of early rectal cancer. Br. J. Surg. 95, 409-423.
34. Ueno H., Murphy J., Jass J.R., Mochizuki H. and Talbot I.C. (2002). Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40, 127-132.
35. Ueno H., Kajiwara Y., Shimazaki H., Shinto E., Hashiguchi Y., Nakanishi K., Maekawa K., Katsurada Y., Nakamura T., Mochizuki H., Yamamoto J. and Hase K. (2012). New criteria for histologic grading of colorectal cancer. Am. J. Surg. Pathol. 36, 193-201.
36. Ueno H., Hase K., Hashiguchi Y., Shimazaki H., Tanaka M., Miyake O., Masaki T., Shimada Y., Kinugasa Y., Mori Y., Kishimoto M., Kameoka S., Sato Y., Matsuda K., Nakadoi K., Shinto E., Nakamura T. and Sugihara K. (2014a). Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am. J. Surg. Pathol. 38, 197-204.
37. Ueno H., Hase K., Hashiguchi Y., Shimazaki H., Yoshii S., Kudo S.E., Tanaka M., Akagi Y., Suto T., Nagata S., Matsuda K., Komori K., Yoshimatsu K., Tomita Y., Yokoyama S., Shinto E., Nakamura T. and Sugihara K. (2014b). Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review. J. Gastroenterol. 49, 1314-1323.
38. Ueno H., Konishi T., Ishikawa Y., Shimazaki H., Ueno M., Aosasa S., Saiura A., Hase K. and Yamamoto J. (2015). Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis. Surgery. 157, 899-908.
39. Verdú M., Román R., Calvo M., Rodón N., García B., González M., Vidal A and Puig X. (2011). Clinicopathological and molecular characterization of colorectal micropapillary carcinoma. Mod. Pathol. 24, 729-738.
40. Verhulst J., Ferdinande L., Demetter P. and Ceelen W. (2012). Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J. Clin. Pathol. 65, 381-388.
41. Xie L., Villeneuve P.J. and Shaw A. (2009). Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int. J. Oncol. 34,1109-1115.
42. Xu F., Xu J., Lou Z., Di M., Wang F., Hu H. and Lai M. (2009). Micropapillary component in colorectal carcinoma is associated with lymph node metastases in T1 and T2 stages and decreased survival time in TNM stages I and II. Am. J. Surg. Pathol. 33, 1287-1292.
43. Young J., Simms L.A., Biden K.G., Wynter C., Whitehall V., Karamatic R., George J., Goldblatt J., Walpole I., Robin S.A., Borten M.M., Stitz R., Searle J., McKeone D., Fraser L., Purdie D.R., Podger K., Price R., Buttenshaw R., Walsh M.D., Barker M., Leggett B.A. and Jass J.R. (2001). Features of colorectal cancers with high-level microsatellite instability occurring in familial and spo-radic settings: parallel pathways of tumorigenesis. Am. J. Pathol. 159, 2107-2116.